5205-11-8

Basic information

• Product Name: BENZOIC ACID 3-METHYL-2-BUTENYL ESTER
• Synonyms: PRENYL BENZOATE;PROFLORA;2-Buten-1-ol,3-methyl-,benzoate;3-methyl-2-buten-1-obenzoate;3-Methylbut-2-enylbenzoate;benzoicacidmethylbutenylester;BENZOIC ACID 3-METHYL-2-BUTENYL ESTER;BENZOIC ACID PRENYL ESTER
• CAS NO: 5205-11-8
• Molecular Formula: C₁₂H₁₄O₂
• Molecular Weight: 190.24
• EINECS: 225-998-7
• Mol File: 5205-11-8.mol
• Article Data: 16

Chemical Properties

• Boiling Point: 107 °C / 2.3mmHg
• Flash Point: 134 °C
• Appearance: /
• Density: 1.03
• Vapor Pressure: 0.00387mmHg at 25°C
• Refractive Index: 1.5190-1.5210
• CAS DataBase Reference: BENZOIC ACID 3-METHYL-2-BUTENYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: BENZOIC ACID 3-METHYL-2-BUTENYL ESTER(5205-11-8)
• EPA Substance Registry System: BENZOIC ACID 3-METHYL-2-BUTENYL ESTER(5205-11-8)

Safety Data

• Hazard Codes: N
• Statements: 50
• Safety Statements: 61
• RTECS: EM9473900
• Hazardous Substances Data: 5205-11-8(Hazardous Substances Data)

Usage

Chemical Properties

Colorless clear liquid; balsam, fruity, chocolate, ylang aroma.

Occurrence

Reported used in Cascarilla bark oil (0.03%), ylang ylang oil I, Cananga odorata Hook. f. and Thomas. (0.11%), ylang ylang oil II, Cananga odorata Hook. f. and Thomas. (0.25%), ylang ylang oil III (0.27%).

Aroma threshold values

Medium strength odor, balsamic type.

InChI:InChI=1/C12H14O2/c1-10(2)8-9-14-12(13)11-6-4-3-5-7-11/h3-8H,9H2,1-2H3

Upstream product

• 65-85-0 benzoic acid 
• 104808-44-8 1-(1-imino-2,2,2-trichloroethoxy)-3-methyl-3-butene 
• 346425-61-4 2-benzoyloxymethyl-3,3-dimethylcyclobutanone 
• 187884-26-0 α-(3-methylbut-2-enyloxy)benzyl hydroperoxide 
• 98-88-4 benzoyl chloride 
• 556-82-1 3-methyl-2-buten-1-ol 
• 93-97-0 benzoic acid anhydride 
• 582-25-2 Potassium benzoate 
• 16722-09-1 trimethylsilyloxirane 
• 4238-09-9 phenyl isopropyl sulfone 
• 93-58-3 benzoic acid methyl ester 
• 4747-15-3 1-(2-methoxyvinyl)benzene 
• 346425-56-7 4-benzoyloxymethyl-2,2-dichloro-3,3-dimethylcyclobutanone 

Downstream Products

• 5205-04-9 (3-hydroxy-3-methylbutyl) benzoate 
• 124946-47-0 C₂₄H₂₆O₄Si 
• 63972-14-5 1-(dimethylphenylsilyl)-3-methyl-2-butene 
• 64904-47-8 2-benzoyloxyacetaldehyde 
• 138240-07-0 Benzoic acid 2,3-dihydroxy-3-methyl-butyl ester 
• 142083-65-6 3-hydroxy-3-methyl-2-oxobutyl benzoate 
• 62894-01-3 (3,3-dimethyloxiran-2-yl)methyl benzoate 
• 350496-21-8 3,3-difluoro-4,4-dimethylhex-5-en-2-one 
• 346425-56-7 4-benzoyloxymethyl-2,2-dichloro-3,3-dimethylcyclobutanone 
• 1206588-63-7 2-hydroxy-3-methylbut-3-en-1-yl benzoate 
• 94-46-2 isoamyl benzoate 

Relevant articles and documents

Base-Promoted Radical Azofluoromethylation of Unactivated Alkenes

The base-induced reaction of aryl diazonium salts with commercially available CF3SO2Na/CF2HSO2Na allows for the generation of the corresponding diazene radicals along with fluoromethyl radicals. The addition of fluoromethyl radicals to alkenes with subsequent diazene trapping provides the azofluoromethylation products in good to excellent yields. This metal-free method under mild reaction conditions has broad functional group compatibility and is applicable in the late-stage modification of various natural products and bioactive molecules.

Epoxide as precatalyst for metal-free catalytic transesterification

Transesterification of methyl esters was accelerated by an in situ-generated metal-free catalyst comprising a quaternary alkylammonium salt and an epoxide. The combination of a quaternary alkylammonium acetate and glycidol is optimal, and various esters were synthesized from methyl esters with alcohols in good to excellent yield. Analysis of the catalyst solution revealed that basic species are generated by the ring-opening reaction of epoxide.

ANTIDIABETIC TRICYCLIC COMPOUNDS

Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment, prevention and suppression of diseases mediated by the G-protein-coupled receptor 40. The compounds of the present invention may be useful in the treatment of Type 2 diabetes mellitus, and of conditions that are often associated with this disease, including obesity and lipid disorders, such as mixed or diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia.